Lymphocyte subset analysis for the assessment of treatment-related complications after autologous stem cell transplantation in multiple myeloma

References

• Hiwase DK, Hiwase S, Bailey M, Bollard G, Schwarer AP. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant. 2008;14:116–24.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Gertz MA, Geyer SM, Litzow MR, Gastineau DA, Moore SB, . The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma. Leukemia. 2004;18:1085–92.
   PubMed Web of Science ®Google Scholar
• Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23:3–9.
   PubMed Web of Science ®Google Scholar
• Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis. 1990;161:397–401.
   PubMed Web of Science ®Google Scholar
• Straka C, Sandherr M, Salwender H, Wandt H, Metzner B, Hubel K, . Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy. Blood. 2011;117:2121–8.
   PubMed Web of Science ®Google Scholar
• Sorror ML, Giralt S, Sandmaier BM, De Lima M, Shahjahan M, Maloney DG, . Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined fhcrc and mdacc experiences. Blood. 2007;110:4606–13.
   PubMed Web of Science ®Google Scholar
• Kim H, Sohn HJ, Kim SE, Kang HJ, Park S, Kim S, . Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma. Bone Marrow Transplant. 2004;34:43–9.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM, Markovic SN. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia. 2002;16:1311–18.
   PubMed Web of Science ®Google Scholar
• Schrama JG, Rodenhuis S, de Gast GC. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Bone Marrow Transplant. 2003;31:141–2.
   PubMedGoogle Scholar
• Porrata LF, Inwards DJ, Micallef IN, Ansell SM, Geyer SM, Markovic SN. Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease. Br J Haematol. 2002;117:629–33.
   PubMed Web of Science ®Google Scholar
• Yoong Y, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Litzow MR, . The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma. Leuk Lymphoma. 2005;46:1287–94.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Gertz MA, Litzow MR, Lacy MQ, Dispenzieri A, Inwards DJ, . Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis. Clin Cancer Res. 2005;11:1210–18.
   PubMed Web of Science ®Google Scholar
• Hiwase DK, Hiwase S, Bailey M, Bollard G, Schwarer AP. The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma. Cytotherapy. 2008;10:507–17.
   PubMed Web of Science ®Google Scholar
• Verbik DJ, Jackson JD, Pirruccello SJ, Patil KD, Kessinger A, Joshi SS. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood. 1995;85:1964–70.
   PubMedGoogle Scholar
• Sharp JG, Kessinger A, Lynch JC, Pavletic ZS, Joshi SS. Blood stem cell transplantation: factors influencing cellular immunological reconstitution. J Hematother Stem Cell Res. 2000;9:971–81.
   Google Scholar
• Rapoport AP, Miller Watelet LF, Linder T, Eberly S, Raubertas RF, Lipp J, . Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol. 1999;17:2446–53.
   PubMed Web of Science ®Google Scholar
• Sonis ST. Oral mucositis in cancer therapy. J Support Oncol. 2004;2:3–8.
   PubMedGoogle Scholar
• Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, . Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332:143–9.
   PubMed Web of Science ®Google Scholar
• Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, . Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet. 2000;355:1875–81.
   PubMed Web of Science ®Google Scholar
• Hakim FT, Memon SA, Cepeda R, Jones EC, Chow CK, Kasten-Sportes C, . Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest. 2005;115:930–9.
   PubMed Web of Science ®Google Scholar
• Cooke KR, Olkiewicz K, Erickson N, Ferrara JL. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res. 2002;8:441–8.
   PubMedGoogle Scholar
• Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood. 1998;92:1471–90.
   PubMed Web of Science ®Google Scholar
• Rutella S, Pierelli L, Bonanno G, Mariotti A, Sica S, Sora F, . Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions. Exp Hematol. 2001;29:1503–16.
   Google Scholar